These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28073243)

  • 1. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.
    Hamed MA; Nakata S; Shiogama K; Suzuki K; Sayed RH; Nishimura Y; Iwata N; Sakurai K; Badawy BS; Inada KI; Tsuge H; Tsutsumi Y
    Clin Exp Otorhinolaryngol; 2017 Sep; 10(3):213-220. PubMed ID: 28073243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Analysis of the Expression of Cytokeratins in Acquired Cholesteatoma and Its Clinico-Radiological Correlation.
    Kanodia A; Kakkar A; Verma Y; Roy D; Verma H; Singh CA; Monga R; Jain D; Thakar A; Sikka K
    J Audiol Otol; 2023 Apr; 27(2):97-103. PubMed ID: 36907202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of Ki-67 and P27 in Cholesteatoma Compared to Skin Tissue Predicts the Prognosis of Adult Acquired Cholesteatoma.
    Türkili S; Görür K; İsmi O; Serinsöz Linke E; Vayısoğlu Y; Özcan C
    J Int Adv Otol; 2021 Jul; 17(4):306-312. PubMed ID: 34309550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing cytokeratin 17 expression in head and neck cancer predicts nodal metastasis and poor prognosis: The first evidence.
    Xu ES; Yang MH; Liu CY; Liu KW; Yang TT; Chou TY; Hwang TZ; Hsu CT
    Clin Otolaryngol; 2018 Aug; 43(4):1010-1018. PubMed ID: 29495101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
    Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren J; Liu W
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2071-2078. PubMed ID: 27981350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.
    Hamed MA; Nakata S; Sayed RH; Ueda H; Badawy BS; Nishimura Y; Kojima T; Iwata N; Ahmed AR; Dahy K; Kondo N; Suzuki K
    Clin Exp Otorhinolaryngol; 2016 Dec; 9(4):298-308. PubMed ID: 27440129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
    Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
    Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
    Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 13, Cytokeratin 17, Ki-67 and p53 Expression in Upper Layers of Epithelial Dysplasia Surrounding Tongue Squamous Cell Carcinoma.
    Matsuhira A; Noguchi S; Sato K; Tanaka Y; Yamamoto G; Mishima K; Katakura A
    Bull Tokyo Dent Coll; 2015; 56(4):223-31. PubMed ID: 26657521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Adenoid Basal Carcinoma: Clinicopathologic Features of 9 Cases With Reference to CK17 and Ki-67 Expression.
    Liang Y; Lü B; Zhou C
    J Low Genit Tract Dis; 2019 Jan; 23(1):77-81. PubMed ID: 30106815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of superficial oral squamous cell malignancy based on morphometry and immunoexpression of cytokeratin 13 and cytokeratin 17.
    Yamashina M; Sato K; Tonogi M; Tanaka Y; Yamane GY; Katakura A
    Acta Cytol; 2014; 58(1):67-75. PubMed ID: 24247036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.
    Leblebici C; Pasaoglu E; Kelten C; Darakci S; Dursun N
    Oncol Lett; 2017 Apr; 13(4):2539-2548. PubMed ID: 28454431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ; Sidey C; Narula AA; James RF
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.